imipramine has been researched along with oxybutynin in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (25.53) | 18.7374 |
| 1990's | 6 (12.77) | 18.2507 |
| 2000's | 18 (38.30) | 29.6817 |
| 2010's | 10 (21.28) | 24.3611 |
| 2020's | 1 (2.13) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Anderson, GF; Fredericks, CM; Green, RL | 1 |
| Levin, RM; Malkowicz, SB; Ruggieri, MR; Wein, AJ | 1 |
| Chun, A; Kato, K; Kitada, S; Levin, RM; Wein, AJ | 1 |
| Bhatia, NN; Karram, MM | 1 |
| Aubert, D; Cencig, P; Royer, M | 1 |
| Pollack, MH; Rosenbaum, JF | 1 |
| Mundy, AR | 1 |
| Rosenthal, JT; Snustad, DG | 1 |
| Applebaum, SM | 1 |
| McGuire, EJ; Savastano, JA | 1 |
| Nasrallah, PF; Simon, JW | 1 |
| Levin, RM; Wein, AJ | 1 |
| Gandhi, KK | 1 |
| Rushton, HG | 1 |
| Steele, BT | 1 |
| Lehmkuhl, G; von Gontard, A | 1 |
| Imada, N; Kawauchi, A; Tanaka, Y; Watanabe, H; Yamao, Y | 1 |
| Clarke, B | 1 |
| Ceylan, S; Dayanç, M; Kibar, Y; Tahmaz, L; Yildirim, I | 1 |
| Evans, JH | 2 |
| Fujinaga, S; Kaneko, K; Ohtomo, Y; Shimizu, T; Yamashiro, Y | 1 |
| Butler, RJ | 1 |
| Cossio, SE | 1 |
| Slagle, M | 1 |
| Giovannini, D; Newman, DK | 1 |
| Hader, C; Keller, T; Welz-Barth, A | 1 |
| Ferrer, FA; Mammen, AA | 1 |
| Dmochowski, RR; Rosenberg, MT | 1 |
| Lee, HJ; Lee, JE; Lee, T; Suh, HJ | 1 |
| Brudermanns, B | 1 |
| Mohanty, NK; Paul, P; Sehgal, R | 1 |
| Abu-Arafeh, W; Chertin, B; Farkas, A; Koulikov, D; Mor, Y; Shenfeld, OZ | 1 |
| Alpendre, C; D'Ancona, CA; Ikari, LY; Natalin, R; Prudente, A; Reis, LO | 1 |
| Caldwell, PH; Deshpande, AV | 1 |
| Bower, WF; Djurhuus, JC; Hagstroem, S; Kamperis, K; Mahler, B; Mikkelsen, MM; Rittig, N; Rittig, S; Siggaard, C | 1 |
| Barbosa, L; da Silva, IB; de Lima, AMJ; Lemos, A; Moretti, E | 1 |
14 review(s) available for imipramine and oxybutynin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic agents in micturitional disorders.
Topics: Baclofen; Bethanechol Compounds; Dantrolene; Dicyclomine; Ephedrine; Flavoxate; Guanethidine; Humans; Imipramine; Mandelic Acids; Methyldopa; Neostigmine; Phenoxybenzamine; Phentolamine; Phenylephrine; Phenylpropanolamine; Propantheline; Propranolol; Quaternary Ammonium Compounds; Urinary Bladder; Urination Disorders | 1980 |
Diagnosis and management of nocturnal enuresis.
Topics: Age Factors; Behavior Therapy; Child; Circadian Rhythm; Clinical Protocols; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandelic Acids; Medical History Taking; Parasympatholytics; Physical Examination; Physician's Role; Recurrence; Treatment Outcome | 1994 |
Older pharmacologic therapy for nocturnal enuresis.
Topics: Adolescent; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandelic Acids; Parasympatholytics | 1993 |
Nocturnal enuresis. Treatment options.
Topics: Administration, Intranasal; Age Factors; Causality; Child; Deamino Arginine Vasopressin; Diagnosis, Differential; Enuresis; Family Practice; Humans; Imipramine; Mandelic Acids; Medical History Taking; Monitoring, Physiologic; Motivation; Parasympatholytics; Sleep; Time Factors; Treatment Failure | 1993 |
[Drug therapy of enuresis].
Topics: Adrenergic Uptake Inhibitors; Animals; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandelic Acids; Parasympatholytics; Renal Agents | 1996 |
Evidence based management of nocturnal enuresis.
Topics: Antidepressive Agents, Tricyclic; Child; Cholinergic Antagonists; Deamino Arginine Vasopressin; Dicyclomine; Enuresis; Humans; Imipramine; Male; Mandelic Acids; Renal Agents; Self-Help Devices | 2001 |
Combination therapy for nocturnal enuresis.
Topics: Antidepressive Agents, Tricyclic; Cholinergic Antagonists; Combined Modality Therapy; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandelic Acids; Multivariate Analysis; Randomized Controlled Trials as Topic; Renal Agents; Time Factors; Wakefulness | 2001 |
Enuresis.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Child, Preschool; Cholinergic Antagonists; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandelic Acids; Renal Agents | 2002 |
The overactive bladder: a nursing perspective.
Topics: Activities of Daily Living; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cost of Illness; Cresols; Female; Humans; Imipramine; Information Services; Male; Mandelic Acids; Mass Screening; Medical History Taking; Muscarinic Antagonists; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Education as Topic; Phenylpropanolamine; Physical Examination; Prevalence; Quality of Life; Social Behavior; Tolterodine Tartrate; Urination Disorders | 2002 |
Nocturnal enuresis: medical management.
Topics: Antidepressive Agents, Tricyclic; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandelic Acids; Physical Examination; Renal Agents; Urodynamics | 2004 |
Overactive bladder: evaluation and management in primary care.
Topics: Algorithms; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Imipramine; Mandelic Acids; Phenylpropanolamine; Primary Health Care; Tolterodine Tartrate; Urinary Incontinence; Urinary Incontinence, Stress | 2005 |
Medical management of nocturnal enuresis.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antidiuretic Agents; Behavior Therapy; Child; Child, Preschool; Cholinergic Antagonists; Deamino Arginine Vasopressin; Humans; Imipramine; Mandelic Acids; Neurophysins; Nocturnal Enuresis; Protein Precursors; Risk Factors; Vasopressins | 2012 |
What do cochrane systematic reviews say about interventions for enuresis in children and adolescents? An overview of systematic reviews.
Topics: Adolescent; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Nocturnal Enuresis; Systematic Reviews as Topic; Urinary Incontinence | 2022 |
6 trial(s) available for imipramine and oxybutynin
| Article | Year |
|---|---|
Effects of systematic treatment based on overnight simultaneous monitoring of electroencephalography and cystometry.
Topics: Adrenergic Uptake Inhibitors; Child; Cholinergic Antagonists; Diagnostic Techniques, Urological; Electroencephalography; Enuresis; Female; Humans; Imipramine; Male; Mandelic Acids; Monitoring, Physiologic; Parasympatholytics; Sleep; Wakefulness | 1998 |
Anticholinergic medication for the unstable bladder: prospective trials of imipramine/propantheline versus penthienate and oxybutynin versus penthienate.
Topics: Adrenergic Uptake Inhibitors; Cholinergic Antagonists; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Humans; Imipramine; Infant, Newborn; Mandelic Acids; Parasympatholytics; Prospective Studies; Quaternary Ammonium Compounds; Treatment Outcome; Urination Disorders | 1996 |
Combination therapy of imipramine with oxybutynin in children with enuresis nocturna.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cholinergic Antagonists; Drug Therapy, Combination; Enuresis; Female; Follow-Up Studies; Humans; Imipramine; Male; Mandelic Acids; Prospective Studies; Single-Blind Method; Time Factors | 2000 |
Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.
Topics: Adolescent; Child; Child, Preschool; Deamino Arginine Vasopressin; Drug Therapy, Combination; Enuresis; Female; Humans; Imipramine; Male; Mandelic Acids; Prognosis; Prospective Studies; Treatment Outcome; Urodynamics | 2005 |
Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.
Topics: Adolescent; Behavior Therapy; Child; Child, Preschool; Enuresis; Female; Flavoxate; Humans; Imipramine; Male; Mandelic Acids; Parasympatholytics; Treatment Outcome; Ultrasonography; Urinary Bladder; Urodynamics | 2007 |
Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
Topics: Antidepressive Agents, Tricyclic; Antidiuretic Agents; Attention Deficit Disorder with Hyperactivity; Child; Deamino Arginine Vasopressin; Drug Therapy, Combination; Enuresis; Female; Humans; Imipramine; Male; Mandelic Acids; Parasympatholytics; Prospective Studies; Treatment Outcome | 2007 |
27 other study(ies) available for imipramine and oxybutynin
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Comparative in vitro effects of imipramine, oxybutynin, and flavoxate on rabbit detrusor.
Topics: Anesthetics, Local; Animals; Barium; Carbachol; Cyclohexanes; Flavonoids; Flavoxate; Humans; Imipramine; In Vitro Techniques; Male; Mandelic Acids; Rabbits; Urinary Bladder; Urodynamics | 1978 |
Comparison of calcium antagonist properties of antispasmotic agents.
Topics: Animals; Calcium; Calcium Channel Blockers; Flavoxate; Imipramine; Ion Channels; Male; Mandelic Acids; Parasympatholytics; Rabbits; Urinary Bladder; Urinary Bladder, Neurogenic | 1987 |
In vitro intravesical instillation of anticholinergic, antispasmodic and calcium blocking agents (rabbit whole bladder model).
Topics: Administration, Intravesical; Animals; Atropine; Bethanechol; Bethanechol Compounds; Calcium Channel Blockers; Imipramine; Male; Mandelic Acids; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Rabbits; Urinary Bladder; Urinary Bladder, Neurogenic | 1989 |
Management of coexistent stress and urge urinary incontinence.
Topics: Adult; Aged; Drug Therapy, Combination; Estrogens; Female; Humans; Imipramine; Mandelic Acids; Middle Aged; Parasympatholytics; Urethra; Urinary Incontinence; Urinary Incontinence, Stress; Urodynamics | 1989 |
[Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
Topics: Adolescent; Child; Child, Preschool; Circadian Rhythm; Female; Humans; Imipramine; Male; Mandelic Acids; Parasympatholytics; Retrospective Studies; Urinary Bladder, Neurogenic; Urinary Catheterization; Urination Disorders | 1986 |
Treatment-emergent incontinence with lithium.
Topics: Adult; Aged; Bipolar Disorder; Female; Humans; Imipramine; Lithium; Lithium Carbonate; Mandelic Acids; Middle Aged; Muscle, Smooth; Urinary Bladder; Urinary Incontinence | 1985 |
The unstable bladder.
Topics: Female; Humans; Imipramine; Mandelic Acids; Propantheline; Psychotherapy; Urinary Bladder; Urinary Bladder Diseases; Urination Disorders; Urine; Urodynamics | 1985 |
Urinary incontinence in the elderly.
Topics: Aged; Female; Humans; Imipramine; Mandelic Acids; Muscle, Smooth; Parasympatholytics; Propantheline; Reflex, Abnormal; Urethral Obstruction; Urinary Bladder; Urinary Incontinence; Urinary Incontinence, Stress; Urinary Tract; Urinary Tract Physiological Phenomena; Urodynamics | 1985 |
Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
Topics: Adult; Aged; Bethanechol; Bethanechol Compounds; Female; Humans; Imipramine; Male; Mandelic Acids; Middle Aged; Multiple Sclerosis; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Phenoxybenzamine; Reflex, Abnormal; Time Factors; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urodynamics | 1984 |
Reflux and voiding abnormalities in children.
Topics: Counseling; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipramine; Male; Mandelic Acids; Urination Disorders; Urodynamics; Vesico-Ureteral Reflux | 1984 |
Direct measurement of the anticholinergic activity of a series of pharmacological compounds on the canine and rabbit urinary bladder.
Topics: Animals; Atropine; Binding, Competitive; Dicyclomine; Dogs; Female; Glycopyrrolate; Imipramine; In Vitro Techniques; Mandelic Acids; Parasympatholytics; Propantheline; Rabbits; Radioligand Assay; Receptors, Cholinergic; Receptors, Muscarinic; Urinary Bladder | 1982 |
Nocturnal enuresis.
Topics: Antidepressive Agents, Tricyclic; Child; Combined Modality Therapy; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Male; Mandelic Acids; Renal Agents | 2001 |
Combined pharmacotherapy for nocturnal enuresis.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Benzilates; Child; Cholinergic Antagonists; Drug Therapy, Combination; Enuresis; Female; Humans; Imipramine; Male; Mandelic Acids; Recurrence | 2001 |
Medication update.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Deamino Arginine Vasopressin; Humans; Imipramine; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Renal Agents; Tolterodine Tartrate; Urinary Incontinence | 2002 |
[Urinary incontinence--treatment].
Topics: Adrenergic Uptake Inhibitors; Behavior Therapy; Benzhydryl Compounds; Benzilates; Biofeedback, Psychology; Cholinergic Antagonists; Contraindications; Cresols; Deamino Arginine Vasopressin; Electric Stimulation Therapy; Female; Humans; Imipramine; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Physical Therapy Modalities; Renal Agents; Tolterodine Tartrate; Urinary Incontinence; Urinary Incontinence, Stress | 2003 |
[Primary enuresis -- combination therapy with oxybutynin plus desmopressin shows good results].
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Antidiuretic Agents; Chi-Square Distribution; Child; Child, Preschool; Deamino Arginine Vasopressin; Drug Therapy, Combination; Enuresis; Female; Humans; Imipramine; Male; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Patient Compliance; Time Factors; Treatment Outcome | 2007 |
Triple therapy in refractory detrusor overactivity: a preliminary study.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antidepressive Agents, Tricyclic; Child; Doxazosin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Prospective Studies; Urinary Bladder, Overactive; Young Adult | 2010 |
Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidiuretic Agents; Biofeedback, Psychology; Child; Child, Preschool; Cohort Studies; Deamino Arginine Vasopressin; Diurnal Enuresis; Enuresis; Female; Follow-Up Studies; Humans; Imipramine; Male; Mandelic Acids; Nocturnal Enuresis; Urinary Bladder, Overactive; Urological Agents | 2014 |